The Europe ovarian cancer market was valued at USD 1,074.5 million in 2023 and is projected to reach USD 1,658.3 million by 2030, growing at a CAGR of 6.3%. Factors include rising incidence rates and advancements in treatment options. https://www.datamintelligence.com/research-report/europe-ovarian-cancer-market